Close up shot of vaccines - glass bottles, ampules and syringe with needle. Good for illustration of flu shot, vaccination and covid-19

Our Work

Latham Watkins Advises Sobi on Collaboration With Enable Injections

September 19, 2024

Global healthcare and life sciences team represents the international biopharmaceutical company in the agreement.

Sobi (STO: SOBI) and Enable Injections, Inc. have announced a global (ex-US) development agreement and supply agreement across Sobi territories for the enFuse Injector, for the subcutaneous delivery of Aspaveli (pegcetacoplan).

Latham & Watkins LLP advised Sobi in the transaction with a corporate deal team led by San Diego partner Steve Chinowsky, London associate Oliver Mobasser, and San Diego counsel Darryl Steensma.

Endnotes

Steven T. Chinowsky

San Diego

steve.chinowsky@lw.com +1.858.523.5400

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.

Endnotes

Contacts

Steven T. Chinowsky